Close

Orion Pharma Animal Health and Vetoquinol Enter Distribution Collaboration from 1 January 2015

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions

Solutions for patient-centred drug delivery devices that enhance dosing,...

Steriline’s Advanced Filling Innovations Exhibited At Interphex 2025

New York City, March 25, 2025 – Steriline, a well-established European manufacturer...

Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs

London, UK: Coronado Research has appointed Gary Lyons as EVP Medical...

Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion’s sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.

Vétoquinol will be the distributor in selected European countries for Orion sedative products. The collaboration is effective from 1 January 2015.

Vetoquinol is responsible for marketing the sedatives to customers in the UK, Germany, France, Ireland, the Netherlands, Belgium, Luxembourg and Italy.

Orion Pharma Animal Health vice-president Niclas Lindstedt said: “Orion Pharma Animal Health foresees that this new alliance with a dedicated and recognised partner will further strengthen the position with customers of the well-accepted Orion sedatives range.”

Vetoquinol CEO Matthieu Frechin said: “The inclusion of the sedative products from Orion Pharma Animal Health in our pain and surgery product range will further reinforce our offer to our customers; it is a an additional proof of our willingness to be a partner of choice for all vet surgeons in the field of pain and anaesthesia.”

Latest stories

Related stories

Berry to Showcase Latest Technologies for Fast-to-Market, Patient-Centric Solutions

Solutions for patient-centred drug delivery devices that enhance dosing,...

Steriline’s Advanced Filling Innovations Exhibited At Interphex 2025

New York City, March 25, 2025 – Steriline, a well-established European manufacturer...

Coronado Research Announce the Appointment of Gary Lyons as EVP Medical Affairs

London, UK: Coronado Research has appointed Gary Lyons as EVP Medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back